139 related articles for article (PubMed ID: 24814262)
1. Frequency distribution of high risk alleles of CYP2C19, CYP2E1, CYP3A4 genes in Haryana population.
Gulati S; Yadav A; Kumar N; Kanupriya ; Kumar G; Aggarwal N; Gupta R
Environ Toxicol Pharmacol; 2014 May; 37(3):1186-93. PubMed ID: 24814262
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP2E1, CYP2A6 and CYP3A5 in South Indian population.
Krishnakumar D; Gurusamy U; Dhandapani K; Surendiran A; Baghel R; Kukreti R; Gangadhar R; Prayaga U; Manjunath S; Adithan C
Fundam Clin Pharmacol; 2012 Apr; 26(2):295-306. PubMed ID: 21265876
[TBL] [Abstract][Full Text] [Related]
3. Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations.
Wang SM; Zhu AP; Li D; Wang Z; Zhang P; Zhang GL
J Hum Genet; 2009 Jun; 54(6):372-5. PubMed ID: 19444287
[TBL] [Abstract][Full Text] [Related]
4. Allele and genotype frequencies of the polymorphic cytochrome P450 genes (CYP1A1, CYP3A4, CYP3A5, CYP2C9 and CYP2C19) in the Jordanian population.
Yousef AM; Bulatova NR; Newman W; Hakooz N; Ismail S; Qusa H; Zahran F; Anwar Ababneh N; Hasan F; Zaloom I; Khayat G; Al-Zmili R; Naffa R; Al-Diab O
Mol Biol Rep; 2012 Oct; 39(10):9423-33. PubMed ID: 22722998
[TBL] [Abstract][Full Text] [Related]
5. Allele and genotype frequencies of CYP3A4, CYP2C19, and CYP2D6 in Han, Uighur, Hui, and Mongolian Chinese populations.
Zuo LJ; Guo T; Xia DY; Jia LH
Genet Test Mol Biomarkers; 2012 Feb; 16(2):102-8. PubMed ID: 22224559
[TBL] [Abstract][Full Text] [Related]
6. Allele and genotype frequencies of polymorphic cytochromes P450 (CYP2C9, CYP2C19, CYP2E1) and dihydropyrimidine dehydrogenase (DPYD) in the Egyptian population.
Hamdy SI; Hiratsuka M; Narahara K; El-Enany M; Moursi N; Ahmed MS; Mizugaki M
Br J Clin Pharmacol; 2002 Jun; 53(6):596-603. PubMed ID: 12047484
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
Zuo J; Xia D; Jia L; Guo T
Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.
Veiga MI; Asimus S; Ferreira PE; Martins JP; Cavaco I; Ribeiro V; Hai TN; Petzold MG; Björkman A; Ashton M; Gil JP
Eur J Clin Pharmacol; 2009 Apr; 65(4):355-63. PubMed ID: 18979093
[TBL] [Abstract][Full Text] [Related]
9. Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors.
Charo LM; Homer MV; Natarajan L; Haunschild C; Chung K; Mao JJ; DeMichele AM; Su HI
J Obstet Gynaecol; 2021 Apr; 41(3):447-452. PubMed ID: 32496149
[TBL] [Abstract][Full Text] [Related]
10. Allele and genotype frequencies of polymorphic cytochromes P4502D6, 2C19 and 2E1 in aborigines from western Australia.
Griese EU; Ilett KF; Kitteringham NR; Eichelbaum M; Powell H; Spargo RM; LeSouef PN; Musk AW; Minchin RF
Pharmacogenetics; 2001 Feb; 11(1):69-76. PubMed ID: 11207032
[TBL] [Abstract][Full Text] [Related]
11. CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro.
Rossini A; Lima SS; Rapozo DC; Faria M; Albano RM; Pinto LF
Braz J Med Biol Res; 2006 Feb; 39(2):195-201. PubMed ID: 16470306
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P4502E1 (CYP2E1) genetic polymorphisms in a Lebanese population: frequency distribution and association with morbid diseases.
Zgheib NK; Mitri Z; Geryess E; Noutsi P
Genet Test Mol Biomarkers; 2010 Jun; 14(3):393-7. PubMed ID: 20406102
[TBL] [Abstract][Full Text] [Related]
13. Significant genotype difference in the CYP2E1 PstI polymorphism of indigenous groups in Sabah, Malaysia with Asian and non-Asian populations.
Goh LP; Chong ET; Chua KH; Chuah JA; Lee PC
Asian Pac J Cancer Prev; 2014; 15(17):7377-81. PubMed ID: 25227845
[TBL] [Abstract][Full Text] [Related]
14. Genetic Polymorphism of Drug-Metabolizing Enzymes CYP2C9 and CYP2C19 in Moroccan Population.
Afilal D; Basselam MA; Brakez Z; Chouham S; Brehm A; Izaabel EH
Genet Test Mol Biomarkers; 2017 May; 21(5):298-304. PubMed ID: 28282224
[TBL] [Abstract][Full Text] [Related]
15. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
Skadrić I; Stojković O
Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
[TBL] [Abstract][Full Text] [Related]
16. Genotype and allele frequencies of polymorphic CYP2E1 in the Turkish population.
Ulusoy G; Arinç E; Adali O
Arch Toxicol; 2007 Oct; 81(10):711-8. PubMed ID: 17380320
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms of CYP2E1 and GSTM1 in a Thai population.
Sangrajrang S; Jedpiyawongse A; Srivatanakul P
Asian Pac J Cancer Prev; 2006; 7(3):415-9. PubMed ID: 17059334
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
[TBL] [Abstract][Full Text] [Related]
19. Cytochrome 3A and 2E1 in human liver tissue: Individual variations among normal Japanese subjects.
Hata S; Miki Y; Fujishima F; Sato R; Okaue A; Abe K; Ishida K; Akahira J; Unno M; Sasano H
Life Sci; 2010 Mar; 86(11-12):393-401. PubMed ID: 20102722
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphisms of CYP2E1 and GSTP1 in a South Indian population--comparison with North Indians, Caucasians and Chinese.
Soya SS; Padmaja N; Adithan C
Asian Pac J Cancer Prev; 2005; 6(3):315-9. PubMed ID: 16235992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
